These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8595734)

  • 21. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
    Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
    Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid and sensitive liquid chromatography-tandem mass spectrometry method for determination of monoethylglycinexylidide.
    Streit F; Niedmann PD; Shipkova M; Armstrong VW; Oellerich M
    Clin Chem; 2001 Oct; 47(10):1853-6. PubMed ID: 11568101
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoethylglycinexylidide (MEGX) liver function test is not compromised by 3-hydroxy MEGX in humans.
    Schütz E; Shipkova M; Armstrong VW; Oellerich M
    Hepatology; 1998 Nov; 28(5):1439-40. PubMed ID: 9794937
    [No Abstract]   [Full Text] [Related]  

  • 24. Lidocaine plasma concentrations following administration of intraoral lidocaine solution.
    Greenblatt DJ; Benjamin DM; Willis CR; Harmatz JS; Zinny MA
    Arch Otolaryngol; 1985 May; 111(5):298-300. PubMed ID: 3985850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of lidocaine metabolite formation as a quantitative liver function test in children.
    Gremse DA; A-Kader HH; Schroeder TJ; Balistreri WF
    Hepatology; 1990 Sep; 12(3 Pt 1):565-9. PubMed ID: 2401461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoethylglycinexylidide and lidocaine determination in porcine microsomal preparations.
    Cox SK; Hamner T; Bartges J
    J Pharm Biomed Anal; 2005 Apr; 37(4):801-4. PubMed ID: 15797804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of lidocaine as a test of liver function in liver transplantation.
    Potter JM; Oellerich M
    Liver Transpl Surg; 1996 May; 2(3):211-24. PubMed ID: 9346651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lidocaine monoethylglycinexylidide test of liver function.
    Ghent CN; Wall WJ
    Liver Transpl Surg; 1996 May; 2(3):242-5. PubMed ID: 9346657
    [No Abstract]   [Full Text] [Related]  

  • 29. Determination of MEGX by HPLC with fluorescence detection.
    Andreeva M; Niedmann PD; Schütz E; Wieland E; Armstrong VW; Oellerich M
    Clin Chem; 1997 Jun; 43(6 Pt 1):1081-3. PubMed ID: 9191566
    [No Abstract]   [Full Text] [Related]  

  • 30. High-performance liquid chromatographic method for the simultaneous determination of lidocaine and its N-dealkylated metabolites in plasma.
    Nation RL; Peng GW; Chiou WL
    J Chromatogr; 1979 Mar; 162(3):466-73. PubMed ID: 528615
    [No Abstract]   [Full Text] [Related]  

  • 31. A HPLC method for the simultaneous determination of disopyramide, lidocaine and their monodealkylated metabolites.
    Angelo HR; Bonde J; Kampmann JP; Kastrup J
    Scand J Clin Lab Invest; 1986 Nov; 46(7):623-7. PubMed ID: 3787162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid analytical procedure for the determination of concentrations of lidocaine and its two active metabolites in canine serum.
    Neff-Davis CA; Wilcke JC; Davis LE
    J Vet Pharmacol Ther; 1982 Dec; 5(4):289-92. PubMed ID: 7183798
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of hydralazine on the pharmacokinetics of orally administered d-propranolol and lidocaine in conscious dogs.
    Heinzow BG; Somogyi A; McLean AJ
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):5-14. PubMed ID: 3592861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GLC assay for lidocaine in human plasma.
    Karch FE; Chmielewski KF
    J Pharm Sci; 1981 Feb; 70(2):229-30. PubMed ID: 7205235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of nonaqueous capillary electrophoresis for the determination of lidocaine and its metabolites in human plasma: a comparison of ultraviolet and mass spectrometric detection.
    Anderson MS; Lu B; Abdel-Rehim M; Blomberg S; Blomberg LG
    Rapid Commun Mass Spectrom; 2004; 18(22):2612-8. PubMed ID: 15481095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of lidocaine by purified rat liver microsomal cytochrome P-450 isozymes.
    Oda Y; Imaoka S; Nakahira Y; Asada A; Fujimori M; Fujita S; Funae Y
    Biochem Pharmacol; 1989 Dec; 38(24):4439-44. PubMed ID: 2604746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoethylglycinexylidide production and prediction of hepatic histology.
    Fabbri A; Bianchi GP; Marchesini G
    Ital J Gastroenterol; 1995; 27(1):40-1. PubMed ID: 7795287
    [No Abstract]   [Full Text] [Related]  

  • 38. Determination of monoethylglycinexylidide by fluorescence polarization immunoassay in highly icteric serum samples: modified precipitation procedure and HPLC compared.
    Schütz E; Shipkova M; Niedmann PD; Wieland E; Armstrong VW; Oellerich M
    Clin Chem; 1998 Jun; 44(6 Pt 1):1269-74. PubMed ID: 9625052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests.
    Meyer-Wyss B; Renner E; Luo H; Scholer A
    J Hepatol; 1993 Aug; 19(1):133-9. PubMed ID: 8301033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test.
    Huang YS; Chiang JH; Wu JC; Chang FY; Lee SD
    Am J Gastroenterol; 2002 May; 97(5):1223-7. PubMed ID: 12014732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.